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Edited by Robert Russell and Giulio Superti-FurgaAbstract Biological systems, from macromolecules to whole
organisms, are robust if they continue to function, survive, or
reproduce when faced with mutations, environmental change,
and internal noise. I focus here on biological systems that are ro-
bust to mutations and ask whether such systems are more or less
evolvable, in the sense that they can acquire novel properties. The
more robust a system is, the more mutations in it are neutral,
that is, without phenotypic eﬀect. I argue here that such neutral
change – and thus robustness – can be a key to future evolution-
ary innovation, if one accepts that neutrality is not an essential
feature of a mutation. That is, a once neutral mutation may
cause phenotypic eﬀects in a changed environment or genetic
background. I argue that most, if not all, neutral mutations
are of this sort, and that the essentialist notion of neutrality
should be abandoned. This perspective reconciles two opposing
views on the forces dominating organismal evolution, natural
selection and random drift: neutral mutations occur and are espe-
cially abundant in robust systems, but they do not remain neutral
indeﬁnitely, and eventually become visible to natural selection,
where some of them lead to evolutionary innovations.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Innovation1. Introduction
The word evolvability has two main usages [1–4]. According
to the ﬁrst of them
a biological system is evolvable
if its properties show heritable genetic variation,
and if natural selection can thus change these properties.
A second usage ties evolvability to evolutionary innovations:
a biological system is evolvable
if it can acquire novel functions through genetic change,
functions that help the organism survive and reproduce.
These deﬁnitions apply to biological systems on all levels of
biological organization, such as macromolecules like RNA and
proteins, metabolic pathways, gene regulation networks, mac-*Fax: +1 505 277 0304.
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doi:10.1016/j.febslet.2005.01.063roscopic traits, and whole organisms. In consequence, func-
tional innovation also comes in many diﬀerent sizes and
shapes, from enzymes with new catalytic activities, to novel
complex organs such as eyes or wings [5].
The two usages are far from synonymous. Most impor-
tantly, not all systems that are evolvable in the ﬁrst sense are
evolvable in the second sense. Consider an enzyme-coding gene
that is subject to diﬀerent mutations in diﬀerent individuals of
a population. These mutations cause the enzymes activity to
ﬂuctuate among diﬀerent individuals. If such heritable genetic
variation aﬀects ﬁtness, perhaps through variations in meta-
bolic ﬂux, then natural selection can change enzyme activity.
The enzymes activity is thus evolvable in the ﬁrst sense. How-
ever, even after millions of years, no mutation might endow
this enzyme with a new catalytic activity, an activity perhaps
that might permit survival in a completely new environment.
Thus, even though it is evolvable in the ﬁrst sense, the enzymes
activity need not be evolvable in the second sense. The con-
verse, however, does not hold. Every system that is evolvable
in the sense of being innovative can evolve by means of natural
selection. Put diﬀerently, the ability to innovate is the more
profound usage of evolvability. It encompasses the ﬁrst usage
and much more. Naturally, we know much less about it.
Living things are unimaginably complex, yet also highly ro-
bust to genetic change on all levels of organization. Proteins
can tolerate thousands of amino acid changes, metabolic net-
works can continue to sustain life even after removal of impor-
tant chemical reactions, gene regulation networks continue to
function after alteration of key gene interactions, and radical
genetic change in embryonic development can lead to an essen-
tially unchanged adult organism [6–9]. Such robustness is one
of several factors that can aﬀect evolvability in either sense
[1]. My central question here is whether robustness fosters or
hinders evolvability. Clearly, robustness will not increase evolv-
ability in the ﬁrst sense. In a highly robust system, a given num-
ber of mutations will have smaller phenotypic eﬀects than in a
less robust system: thus, robustness reduces the amount of her-
itable genetic variation on which selection can act. But, more
importantly, does robustness hinder or foster innovation? This
is a more diﬃcult problem, and my focus in this article.
One can adopt two conﬂicting perspectives on this problem.
The ﬁrst arises from the observation that robustness causes
many mutations to be neutral, mutations with no phenotypic
eﬀect on the system. Neutral mutations, by deﬁnition, are
invisible to natural selection and can thus not be the source
of innovation. Thus, increased robustness means fewer evolu-
tionary innovations. The second perspective, in contrast, gives
neutral mutations a key role in innovation: although manyation of European Biochemical Societies.
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tion, they can change other system features, features that har-
bor the seeds of future evolutionary change. Put diﬀerently, a
system capable to fulﬁll its primary function in many diﬀerent
conﬁgurations – explorable through mutation – has suﬃcient
ﬂexibility and degrees of freedom to adopt other features. To
use Goulds term [10] of exaptations – organismal features that
may become adaptations only long after they arise – robust-
ness facilitates exaptations. From this perspective, neutral
mutations themselves are the key to evolutionary innovation:
Robustness implies that many mutations are neutral and such
neutrality fosters innovation.2. Neutrality, can it be assessed experimentally?
A key diﬀerence between the two perspectives of the last two
paragraphs is their tacit understanding of neutrality. I will now
examine this notion more closely. Neutral genetic change,
made prominent by Kimura [11] in his neutral theory of molec-
ular evolution, is commonly understood as genetic change that
does not aﬀect an organisms ﬁtness. In addition, neutral
change has to be neutral in any environment, physiological
condition, or genetic background. I will call this the essential-
ist view of neutral change, where being neutral is a property
only of a mutation itself – it is part of the essence of that
mutation – and not of any other factor such as the genetic
background.
These two aspects of neutralitys deﬁnition also encapsulate
its biggest problems. First, how can we determine whether a
mutation does not aﬀect ﬁtness? Beyond the commonplace
that ﬁtness means the ability to survive and reproduce, ﬁtness
is diﬃcult to deﬁne properly, and nearly impossible to measure
rigorously [12]. To give a simple example, laboratory evolution
experiments in microbes often use cell division rates of bacte-
rial strains as an indicator of ﬁtness. While growth rate is cer-
tainly an important aspect of ﬁtness, a myriad other equally
important aspects exist, including survival under starvation
conditions, heat-resistance, sporulation eﬃciency, germination
rates, and so on. In addition, growth rates themselves could be
measured in countless diﬀerent laboratory environments.
Which of these would be most representative of the environ-
ments a microbe encountered in its recent evolutionary past?
The answer is usually unknown and perhaps often unknow-
able. Such problems are exacerbated in higher organisms,
where sexual reproduction, age-speciﬁc mortality and fertility,
an increased ability to change the environment, and smaller
population sizes pose daunting principal and technical prob-
lems. Taken together, these diﬃculties mean that an unassail-
able measurement of any organisms ﬁtness does in practice
not exist.
A second candidate approach to identify neutral mutations
applies to well-understood systems inside an organism. For
example, assume you are concerned with the neutrality of a
mutation in a mundane gene, such as that encoding the glyco-
lytic enzyme phosphoglucose isomerase. This enzyme intercon-
verts glucose 6-phosphate and fructose 6-phosphate. To
determine whether a mutation in its gene is neutral, you could
simply measure the mutations eﬀect on enzyme activity. The
approach seems simple enough, but it is doomed to fail. The
reason is that many proteins have multiple and unforeseeablebiochemical activities or biological functions. Phosphoglucose
isomerase itself serves as an example [13]. In vertebrates, it is
the same protein as neuroleukin, a cytokine causing immune
cell maturation, and survival of some embryonic spinal nerve
cells [14,15]. In addition, phosphoglucose isomerase also serves
as autocrine motility factor [16], a cytokine that stimulates cell
migration. As if that were not enough, it can also cause diﬀer-
entiation of human myeloid leukemia cells [17]. Who knows
what other functions await discovery?
Phosphoglucose isomerase is no exception in its multifunc-
tionality. Aminoacyl tRNA synthetases, the enzymes that
charge RNAs with amino acids for translation, can also bind
DNA and regulate transcription, bind messenger RNA and
regulate translation, participate in the splicing of some messen-
ger RNA, act as co-factors in RNA traﬃcking, and stimulate
chemotaxis of immune cells [18]. Among a long list of further
examples [13] is thymidine phosphorylase, which catalyzes the
dephosphorylation of thymidine and deoxyuridine, and is the
same as an endothelial growth factor [19,20].
The same holds of course also for systems on other levels of
biological organization. Perhaps, the most notable examples
come from regulatory gene networks like the segment polarity
network. Here, some network genes or the whole network can
serve to pattern diﬀerent body regions at diﬀerent times in
development [21,22]. Taken together, all these examples show
that measuring changes in well-understood aspects of a pro-
teins function may thus be highly misleading in identifying
neutral mutations: one can simply never be sure of having
identiﬁed all aspects of a proteins biological function. These
examples also show that we can never be sure that all the right
questions have been asked.3. The evolutionary approach to identifying neutrality
The last paragraphs show that neither ﬁtness nor a biolog-
ical systems performance – that is, all conceivable aspects of
it – can be measured in practice. If so, one might think that
the above deﬁnition of (ﬁtness-centered) neutrality is opera-
tionally useless. However, experimentation is not the only
way to ascertain the neutrality of mutations. The alternative
is an evolutionary approach that rests on the second aspect of
neutralitys deﬁnition, namely that a neutral mutation must
be neutral regardless of physiological state, environment, or
genetic background. I will brieﬂy discuss this approach and
ask whether it can rescue the essentialist concept of neutral-
ity. The approach takes advantage of a simple yet fundamen-
tal population genetic insight: Neutral mutations that occur
in a population go to ﬁxation (they attain a population fre-
quency of one) at a clock-like and constant rate [11]. Impor-
tantly, this rate depends only on the rate at which neutral
mutations occur, and not on other factors, such as popula-
tion size. The rate is thus independent of the peculiarities
of a populations demographic history. This does not apply
to mutations subject to natural selection, whose fate is inﬂu-
enced by such factors.
A wide variety of tests ask whether this and similar proper-
ties hold for the genetic variation that occurs in a population.
Such tests can be used to ask whether many (or any) mutations
found in a population are neutral. Although these tests have
weaknesses, including a frequent lack of statistical power
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ties of populations, they are the currently best available ap-
proaches to detect neutral mutations [23]. These tests
compare variation either in nucleotide or amino acid sequences
within and between species. Most mutations or alleles that are
detectable in a population have moderate to large frequencies
and are thus old, at least many generations old, but often sev-
eral million years old. Thus, by studying mutations that have
arisen a long time ago, such methods essentially average over
all the diﬀerent genetic backgrounds – variation in other parts
of the genome – that a mutation may have encountered, and
over all the environments to which an organism was exposed.
To demonstrate neutrality, these tests thus require that neu-
trality is an essential feature – in the above sense – of a
mutation.
Are there many mutations that behave neutrally when
viewed from this evolutionary perspective? This question be-
came part of the 20th centurys neutralist–selectionist debate.
The neutralist camp argued that the vast majority of genetic
variation observed in natural populations is neutral variation,
whereas the selectionist camp argued that much of it is inﬂu-
enced by natural selection. If one had to take score after more
than 30 years of debate and data analysis, the selectionists
would clearly win by points [24–26]. One of the key insights
that emerged from the neutralist–selectionist debate is that
even the most obvious candidates for neutral mutations have
provided evidence for selection. Among the best examples
are mutations in a gene that change one codon into another
codon for the same amino acid. Such synonymous mutations
are paradigmatic candidate examples of neutral mutations.
Yet such mutations can reduce the rate at which a messenger
RNA is translated into protein, if they occur towards a codon
whose corresponding transfer RNA is sparse in the cell. Thus,
synonymous mutations, especially those at genes that need to
be highly expressed, are subject to selection [27–29]. In addi-
tion, if a genes optimal expression level changes over time,
then the strength of selection on its synonymous mutations
may also change.
It is easy to conceive of potential examples for neutral muta-
tions other than synonymous mutations. They include muta-
tions in gene-poor parts of the genome, such as telomeric
regions and heterochromatin, or mutations in non-coding
and non-regulatory DNA. Such candidates for neutral muta-
tions are less-well studied, but they can still serve to illustrate
how genetic variation or environmental change could lead to
selection acting on neutral mutations. Consider mutations
deep in a region of non-coding human heterochromatin, per-
haps in a sequence that is a member of the Alu-family of short
repetitive interspersed elements [30]. Such mutations are classi-
cal candidate example of neutral mutations, mutations in
junk DNA. However, because genome rearrangements large
and small are frequent in many eukaryotes [31], such DNA ele-
ments can come to reside in the vicinity of a gene, where pre-
viously neutral mutations can aﬀect transcription, translation,
or splicing, and thus be all but neutral.
These two classes of examples – synonymous mutations and
mutations in non-coding DNA – all regard the dependency of
neutrality on genetic background. But what about dependency
on environmental change? Potential examples of this kind of
dependency are also numerous, and I will just cite examples
from two maximally diverse organisms, bacteria and humans.
The ﬁrst example is very simple. Consider a mutation in an en-zyme-coding gene that changes a bacteriums ability to extract
energy from a carbon source such as gluconate. Such a muta-
tion may not aﬀect ﬁtness in environments dominated by other
sugars, but can do so strongly if gluconate is the sole carbon
source [32]. More generally, many metabolic genes that are dis-
pensable in one environment may be essential in another. This
notion is consistent with the observation that intracellular par-
asites, which live in very stable and nutrient-rich environments,
shed many metabolic genes that would be essential in free-
living organisms [33–35].
A second, more complex example regards a human cancer,
hereditary paraganglioma type 1. This cancer is caused by
mutations in the gene encoding the enzyme succinate dehydro-
genase, which is thought to be involved in oxygen sensing [36].
The incidence and severity of this disease are greater in higher
elevations with lower oxygen concentrations than in lower ele-
vations with higher oxygen concentrations. In other words,
chronic hypoxia is a risk factor for paragangliomas. The pop-
ulation genetics of this disease has been studied comparatively
in two human populations living at diﬀerent average altitudes,
one in the Netherlands (low altitude), and another one in the
US (higher altitude) [36]. The population genetic and epidemi-
ological data indicate that at least some alleles associated with
this disease can spread through random genetic drift in the
Dutch population, but not in the US population, where natu-
ral selection is stronger [36]. In other words, some alleles
of succinate dehydrogenase are more likely to be neutral
in an oxygen-rich environment than in an oxygen-poor
environment.
It takes little imagination to come up with other circum-
stances under which natural selection could favor or eliminate
any conceivable mutation that would appear neutral at ﬁrst
glance. With this in mind, it appears much less surprising that
studies of molecular evolution – typically averaging over many
millennia of genetic and environmental change – suggest that
the majority of mutations do not behave neutrally but have
been under the inﬂuence of natural selection. Equally impor-
tant is the suggestion – from studies of enzyme polymorphisms
– that such selection pressures on mutations are not constant
but vary over time [26]: a mutation may aﬀect ﬁtness at some
times but not at others.4. A diﬀerent perspective on neutrality
In sum, if one insists on an essentialist, ﬁtness-centered def-
inition of neutrality, then neutral mutations may be extremely
rare or non-existent. The main reason is that one can always
conceive of a genetic or environmental change that renders a
previously neutral mutation beneﬁcial or detrimental. One
may thus be inclined to abandon the concept altogether as
practically useless.
But what about the many examples of biological systems
highly robust to mutations? They include enzymes that can tol-
erate thousands of amino acid changes, genetic networks that
can produce the same gene expression pattern despite widely
varying gene interactions, developmental pathways that can
buﬀer much genetic variation, microbes and higher organisms
that can tolerate the elimination of many genes, and diﬀerent
cell division and interaction patterns that lead to the formation
of the same organ or organism [6–9,37]. What to call genetic
change that does not aﬀect these systems? ‘‘Neutral’’ is of
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text requires a radical change in deﬁnition.
First, we have to abandon the notion that a neutral change
must not ever aﬀect ﬁtness, either now or in the future. As I
argued above, this notion is operationally of limited use, and
any neutral change can be turned non-neutral through suitable
genetic and environmental change. Instead, we should focus on
one speciﬁc aspect of a systems function, such as its ability to
form a tertiary structure, catalyze a chemical reaction, bind
DNA, produce a gene expression pattern, or form an intact or-
gan. (With the help of good biological intuition and luck, we
will of course study system properties that bear on an organ-
isms ability to survive or to reproduce.)
Second and relatedly, we must abandon an essentialist no-
tion of neutrality. That is, a once neutral mutation may aﬀect
the systems function in a changed environment or genetic
background. Because of its importance, I will illustrate this
principle with some further examples, the ﬁrst of which regards
RNA molecules.
For many RNA molecules, the right secondary structure is a
prerequisite for their function. This is well known for second-
ary structure elements of messenger RNAs, and for the gen-
omes of RNA viruses [38–46]. It means two things. First,Fig. 1. Neutral changes that make a diﬀerence. The ﬁgures show the computa
molecule. Gray bullets on the upper two secondary structures indicate neut
change does not alter the structure. In the top left sequence, position x is neut
the right hand side of the top. However, neutral positions themselves change
the black bullet (‘‘’’) indicate positions that have become neutral or st
substitution. The lower part illustrates that the neutral Cﬁ G mutation at
neutral) position y, that is, the structural changes this non-neutral Aﬁ G
Fontana [47].changing the molecules structure may aﬀect its function. Sec-
ond, a mutations neutrality with respect to secondary struc-
ture becomes a worthwhile subject of study. Fig. 1 kindly
provided by W. Fontana, illustrates how genetic change in
an RNA molecule can inﬂuence the neutrality of a mutation,
in the sense that the mutation does not change the molecules
minimum free energy secondary structure [47]. Speciﬁcally, the
Cﬁ G substitution at one particular position – in and by itself
neutral – changes the number of possible neutral substitutions
at other positions. That is, mutations that were previously neu-
tral at some of these positions now alter the secondary struc-
ture and are no longer neutral [47].
An example from elsewhere in the biological hierarchy is
cryptic variation in developmental genes. Neutral variation
in these genes is variation that does not perturb the develop-
ment of complex organs like eyes, wings and legs. Such varia-
tion becomes non-neutral if certain genes, such as the gene
encoding the heat shock protein Hsp90, undergo mutation.
As a result of such mutations, genetic variation in phenotypic
characters such as eyes and wings increases. Natural selection
can readily act on this phenotypic variation [48].
Yet another example is provided by ‘‘monogenic’’ diseases,
which are diseases typically attributed to mutations in onetionally predicted minimum-free energy secondary structure of an RNA
ral positions, that is, positions where at least one possible nucleotide
ral, because a Cﬁ G substitution preserves the structure, as shown on
as a result of this neutral substitution. The dark gray bullets (‘‘+’’) and
opped being neutral, respectively, as a consequence of this CﬁG
position x changes the consequences of changing A to G at the (non-
mutation causes. Redrawn from a ﬁgure kindly provided by Walter
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eases show that the notion of one disease-causing genes is
vastly oversimpliﬁed: for very common genetic diseases such
as cystic ﬁbrosis, phenylketonuria, and thalassemia, one and
the same mutation may cause severe disease in one individual,
and have a lesser or even no eﬀect in another individual [49,50].
The reasons are both genetic and environmental. A ﬁnal,
environmental example is provided by the sensitivity of photo-
synthesis to the activity of the enzyme Rubisco (ribulose-
1,5-bisphosphate carboxylase-oxygenase) in tobacco. This
sensitivity varies drastically with the lighting conditions under
which plants are grown [51].
In sum, it may be best to deﬁne neutral mutations in the fol-
lowing way:A neutral mutation does not change one aspect of a biolog-
ical systems function in a speciﬁc environment and genetic
background.
This is no longer an essentialist deﬁnition of neutrality: a
mutations neutrality depends not only on the mutation itself
but on its interactions with other genes and the environment.
Both may change over time.
I note in passing that the abandonment of essentialist con-
cepts has successful precedents in the history of biology.
This point is illustrated by the demise of essentialist species
concepts such as the 19th centurys typological species con-
cept [52]. Whether an organism belonged to a particular spe-
cies according to this concept was an essential property of
the organism, a property only of one organisms features.
However, because organisms vary greatly in their features
within a population, this species concept is of limited use.
It was replaced by other species concepts, most notably
the biological species concept, which is a non-essentialist
concept. The biological species concepts centers not on prop-
erties of individuals, but on their interactions and on their
location, speciﬁcally on the ability to reproduce with each
other.
What would we gain by adopting this non-essentialist per-
spective on neutrality? First and most simply, a name, a
name for an aspect of a biological system that remains
unperturbed in the face of change. Second, this perspective
buys us the ability to make distinctions among diﬀerent fea-
tures of a system. While one feature – say its most stable
secondary structure – may be unaﬀected by a mutation, an-
other feature – such as the thermodynamic stability of this
structure – may be aﬀected profoundly. Such distinctions
facilitate understanding how neutral change can lead to
innovation.
Naturally, changing our perspective on neutrality also has a
price. Most importantly, we lose the great generality and con-
ceptual clarity that comes with any essentialist concept. Unfor-
tunately, essentialism is for a simpler world than ours: an
essentialist notion of neutrality may not apply to anything.
The second price to pay is that we abandon the tight linkage
between neutrality and ﬁtness. But it was precisely this linkage
that rendered ﬁtness-neutrality of questionable value: Measur-
ing the ﬁtness eﬀect of any one aspect of a systems function is
impossible; and on the long time scales of molecular evolution
studies, most mutations are not ﬁtness-neutral. Thirdly, like
any other concept, the non-essentialist concept of neutrality
will have limitations and grey areas where its application is
awkward.5. Neutrality and innovation
If we adhere to the traditional, essentialist notion of a neu-
tral mutation, then neutral mutations are irrelevant to innova-
tion and evolvability. If a neutral mutation must not aﬀect
ﬁtness under any circumstances, it could not possible have
anything to do with new adaptation. This is at the heart of
the perspective that neutrality hinders innovation. However,
if we view neutrality as restricted to one aspect of a system,
then other (changed) aspects may provide new adaptations
or exaptations. Then, neutrality can become key to innovation.
Many possible examples could be used to illustrate anecdot-
ally how neutral change in this sense could foster innovation
[2]. Unfortunately, there are few well-studied examples, and
most of these come from the molecular level of organization.
I will discuss a few examples related to systems I discussed
above. They all contain loopholes and are suggestive rather
than conclusive. To close these loopholes is a major task of fu-
ture research in this area.
Computational work on RNA structure shows how repeated
mutations, neutral with respect to RNA secondary structure,
can explore a space of RNA sequences such that new structures
– structural innovations – can become more accessible through
singlemutations.An important experiment bySchultes andBar-
tel [53] suggests that a similar principle may apply not only to
secondary structure – a proxy for some aspects of RNA function
– but also to biological activities of RNAs, such as the catalytic
activities of ribozymes. These authors showed that two ribo-
zymes with radically diﬀerent tertiary structures and very diﬀer-
ent catalytic activities can be converted into each other by a
series of single point mutations. Most of these point mutations
do not reduce catalytic activity and are neutral. Some of the
intermediate sequences possess both catalytic activities, albeit
at reduced rates. This suggests that the robustness of ribozymes
to pointmutations, even if it does not lead all theway to catalytic
innovations, paves the ground for such innovations.
A second class of candidate examples regards the multifunc-
tional proteins for which I mentioned some examples earlier.
Multifunctional proteins such as phosphoglucose isomerase
and thymidine phosphorylase occur both in eukaryotes and
in prokaryotes. Their original and still essential enzymatic
function thus predates other functions, such as the cell signal-
ing functions important to many-celled organisms. Have the
eukaryotic proteins acquired the ability to carry out these
functions after the origin of multicellularity? If so, change neu-
tral with respect to early enzymatic functions may have lead to
innovations in these proteins.
A recent laboratory study of enzyme evolution provides a
diﬀerent twist on this question [54]. The study regards the evo-
lution of three diﬀerent enzymes, each of which has one pri-
mary catalytic function and several other, much weaker
catalytic activities. One of these enzymes is human serum
paraoxonase (PON1). Its primary activity is the hydrolytic
cleavage of lactones (cyclic esters). A laboratory evolution
experiment shows that this enzyme can readily acquire a mas-
sively increased ability to hydrolyze a synthetic organophos-
phate without greatly changing its primary activity. Similar
results hold for the other two enzymes [54].
In some cases, such as crystallins, evolutionary innovations
required a tissue-speciﬁc increase in gene expression. Crystal-
lins are proteins with a variety of functions that have been
co-opted as lens proteins in the eye. In the eye lens their high
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have undergone gene duplication, but non-duplicated crystal-
lins also exist. They include e-crystallin, which is the same as
lactate dehydrogenase and s-crystallin, which is the same as
a-enolase [55,56]. In such non-duplicated crystallins changes
in regulatory DNA regions have occurred that allow enhanced
gene expression in the lens. Regulatory regions serve as prime
examples of how genetic change may be neutral in one respect
– gene expression in one tissue – and yet lead to innovation in
other tissues. The root cause of such neutrality is the vastness
of eukaryotic regulatory regions. Small islands of transcription
factor binding sites are separated by huge swaths of DNA in
which mutations can readily give rise to new binding motifs
for transcription factors by chance alone [57]. Even in lower
eukaryotes such as yeast – which has much smaller regulatory
regions than higher eukaryotes – regulatory regions can evolve
extremely rapidly.
Candidate examples of neutral change leading to innovation
can also be found at the next-higher level of biological organi-
zation, that of genetic networks. One case in point is provided
by the genes of the segment polarity gene network in the fruit
ﬂy Drosophila melanogaster. This network is critical to proper
segmentation of the ﬂy embryo, and many of its genes have
highly conserved function and expression patterns that may
drive segmentation in all insects. Yet these genes have also
been redeployed to pattern organismal features that arose after
the insect body plan. An example is the eyespot of butterﬂies,
which is an evolutionary innovation speciﬁc to some Lepidop-
tera and serves to avoid predators. Several segment polarity
genes are involved in eyespot formation, where their regulatory
interactions are diﬀerent from those they show during early
segmentation [22].
All these examples indicate that biological systems can retain
old functions while acquiring new functions. Whether these
new functions originated as adaptations or exaptations, that
is, whether the new functions originated long after the old
ones, remains to be seen. At the very least, however, these
examples suggest that change neutral with respect to one as-
pect of function could lead to innovation in other aspects.
For most systems, robustness means that they can harbor a
large reservoir of neutral mutations and, as a by-product, a
greater potential for innovation. It is, for instance, no coinci-
dence that the evolution of regulatory regions is the root cause
of many – although not all [58] – adaptations that distinguish a
human from a monkey [59]. It is a sign of how important neu-
tral change, properly deﬁned, can be for innovation.
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